Cerevel Therapeutics (NASDAQ:CERE) Downgraded to Neutral at Cantor Fitzgerald
Cantor Fitzgerald cut shares of Cerevel Therapeutics (NASDAQ:CERE – Free Report) from an overweight rating to a neutral rating in a report issued on Thursday, MarketBeat reports. Cantor Fitzgerald currently has $45.00 price objective on the biotechnology company’s stock, up from their previous price objective of $38.00. A number of other brokerages have also recently […]
More Stories
Ping An Healthcare and Technology Company Limited (OTCMKTS:PANHF) Sees Large Increase in Short Interest
Ping An Healthcare and Technology Company Limited (OTCMKTS:PANHF – Get Free Report) was the recipient of a large growth in...
Short Interest in NEXON Co., Ltd. (OTCMKTS:NEXOF) Increases By 18.5%
NEXON Co., Ltd. (OTCMKTS:NEXOF – Get Free Report) saw a large growth in short interest in the month of December....
Franklin U.S. Low Volatility High Dividend Index ETF (NASDAQ:LVHD) Plans Dividend of $0.35
Franklin U.S. Low Volatility High Dividend Index ETF (NASDAQ:LVHD – Get Free Report) declared a dividend on Monday, December 30th,NASDAQ...
Regis Resources Limited (OTCMKTS:RGRNF) Sees Significant Growth in Short Interest
Regis Resources Limited (OTCMKTS:RGRNF – Get Free Report) was the recipient of a large growth in short interest in the...
Angel Oak High Yield Opportunities ETF (NASDAQ:AOHY) Raises Dividend to $0.07 Per Share
Angel Oak High Yield Opportunities ETF (NASDAQ:AOHY – Get Free Report) declared a dividend on Monday, December 30th,NASDAQ Dividends reports....
Canada Carbon (CVE:CCB) Trading 100% Higher – Here’s What Happened
Canada Carbon Inc. (CVE:CCB – Get Free Report)’s stock price traded up 100% during mid-day trading on Tuesday . The...